8p12 stem cell myeloproliferative disorder: The FOP-fibroblast growth factor receptor 1 fusion protein of the t(6;8) translocation induces cell survival mediated by mitogen-activated protein kinase and phosphatidylinositol 3-kinase/Akt/mTOR pathways

Molecular and Cellular Biology

Volumn 21, Issue 23, 2001, Pages 8129-8142

  Guasch, G ^a   Ollendorff, V ^a   Borg, J P ^a   Birnbaum, D ^a   Pebusque M J ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 9; FIBROBLAST GROWTH FACTOR RECEPTOR; HYBRID PROTEIN; MAMMALIAN TARGET OF RAPAMYCIN; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL KINASE; PHOSPHOLIPASE C; PROTEIN FOP; PROTEIN KINASE B; S6 KINASE; STAT1 PROTEIN; STAT3 PROTEIN; STAT5 PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CHROMOSOME 6; CHROMOSOME 8; CHROMOSOME 8P; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; EOSINOPHILIA; HEMATOPOIETIC CELL; HEMATOPOIETIC STEM CELL; LYMPHOMA; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; CASPASE 9; CASPASES; CELL LINE; CELL SURVIVAL; CHROMOSOMES, HUMAN, PAIR 6; CHROMOSOMES, HUMAN, PAIR 8; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HEMATOPOIETIC STEM CELLS; HUMANS; ISOENZYMES; LEUCINE; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MUTAGENESIS, SITE-DIRECTED; MYELOPROLIFERATIVE DISORDERS; ONCOGENE PROTEINS, FUSION; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; RECEPTORS, FIBROBLAST GROWTH FACTOR; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; TRANSLOCATION, GENETIC;

EID: 0035167404     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.23.8129-8142.2001     Document Type: Article

References (87)

1. Mechanism of activation of protein kinase B by insulin and IGF-1
2. Signal transduction pathways activated and required for mammary carcinogenesis in response to specific oncogenes
3. A role of the kinase mTOR in cellular transformation induced by the oncoproteins P3k and Akt
4. Protein kinase B (c-Akt), phosphatidylinositol 3-kinase, and STAT5 are activated by erythropoietin (EPO) in HCD57 erythroid cells but are constitutively active in an EPO-independent, apoptosis-resistant subclone (HCD57-SREI cells)
5. Ligand induced transphosphorylation between different FGF receptors
6. Oncogenic kinase signalling
7. STATs in oncogenesis
8. Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development
9. Stat3 as an oncogene
10. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction
11. Characterization and cDNA cloning of phospholipase C-gamma, a major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase
12. Fibroblast growth factor receptors: Lessons from the genes
13. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
14. Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas
15. Regulation of cell death protease caspase-9 by phosphorylation
16. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12
17. Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3
18. Activated fibroblast growth factor receptor 3 is an oncogene that contributes to tumor progression in multiple myeloma
19. Dissociation of apoptosis from proliferation, protein kinase B activation, and BAD phosphorylation in interleukin-3-mediated phosphoinositide 3-kinase signaling
20. Cellular survival: A play in three Akts
21. Bcl-2 expression by myeloid precursors in myelodysplastic syndromes: Relation to disease progression
22. PI 3-kinase: Structural and functional analysis of intersubunit interactions
23. Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors
24. Mechanisms and consequences of activation of protein kinase B/Akt
25. ICE-LAP6, a novel member of the ICE/Ced-3 gene family, is activated by the cytotoxic T cell protease granzyme B
26. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression
27. Activation of phospholipase C gamma by PI 3-kinase-induced PH domain-mediated membrane targeting
28. Identification of a novel inhibitor of mitogen-activated protein kinase kinase
29. Met receptor tyrosine kinase: Enhanced signaling through adapter proteins
30. Regulation of translation initiation by FRAP/mTOR
31. Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo
32. New role for Shc in activation of the phosphatidylinositol 3-kinase/Akt pathway
33. FGFR1 is fused to the centrosome-associated protein CEP110 in the 8p12 stem cell myeloproliferative disorder with t(8;9)(p12;q33)
34. Suppression of apoptosis induced by growth factor-withdrawal by an oncogenic form of c-CBL
35. 1-Phosphatidylinositol 3-kinase activity is required for insulin-stimulated glucose transport but not for RAS activation in CHO cells
36. Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
37. K-sam-related gene, N-sam, encodes fibroblast growth factor receptor and is expressed in T-lymphocytic tumors
38. Signalling via phosphoinositide 3OH kinases
39. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death
40. Rapamycin suppresses 5′TOP mRNA translation through inhibition of p70s6k
41. The role of tyrosine phosphorylation in proliferation and maturation of erythroid progenitor cells-signals emanating from the erythropoietin receptor
42. Shc and a novel 89-kDa component couple to the Grb2-Sos complex in fibroblast growth factor-2-stimulated cells
43. Signal transduction by fibroblast growth factor receptors
44. A lipid-anchored Grb2-binding protein that links FGF-receptor activation to the Ras/MAPK signaling pathway
45. A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia
46. Transforming properties of chimeric TEL-JAK proteins in Ba/F3 cells
47. Ras-dependent growth factor regulation of MEK kinase in PC12 cells
48. Divergent roles of STAT1 and STAT5 in malignancy as revealed by gene disruptions in mice
49. The role of Stat5a and Stat5b in signaling by IL-2 family cytokines
50. Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukemia
51. Genes altered by chromosomal translocations in leukemias and lymphomas
52. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Fig) is a binding site for the SH2 domain of phospholipase C-γ1
53. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction
54. Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor
55. The 8p12 myeloproliferative disorder. t(8;19)(p12;q13.3): A novel translocation involving the FGFR1 gene
56. The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and-independent pathways: Roles for phosphatidylinositol 3-kinase and Raf
57. Characterization of FIM-FGFR1, the fusion product of the myeloproliferative disorder-associated t(8;13) translocation
58. FRS2 proteins recruit intracellular signaling pathways by binding to diverse targets on fibroblast growth factor and nerve growth factor receptors
59. Inhibition of MAP kinase kinase blocks the differentiation of PC-12 cells induced by nerve growth factor
60. The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain
61. Multiple signaling pathways of the insulin-like growth factor 1 receptor in protection from apoptosis
62. Ectopic expression of fibroblast growth factor receptor 3 promotes myeloma cell proliferation and prevents apoptosis
63. A mitogen-activated protein kinase pathway is required for mu-opioid receptor desensitization
64. Fibroblast growth factor receptor 1 is fused to FIM in stem-cell myeloproliferative disorder with t(8;13)(p12q12)
65. The t(6;8)(q27;p11) translocation in a stem cell myeloproliferative disorder fuses a novel gene, FOP, to fibroblast growth factor I
66. Phosphatidylinositol 3-kinase signals activate a selective subset of Rac/Rho-dependent effector pathways
67. Consistent fusion of ZNF198 to the fibroblast growth factor receptor-1 in thet(8;13)(p11;q12) myeloproliferative syndrome
68. A novel chromosomal translocation t(4;14)(p16.3;q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene
69. How receptor tyrosine kinases activate Ras
70. Growth factor signaling by receptor tyrosine kinases
71. TOR, a central controller of cell growth
72. The t(8;13)(p11;q11-12) rearrangement associated with an atypical myeloproliferative disorder fuses the fibroblast growth factor receptor 1 gene to a novel gene RAMP
73. Two color FISH to detect FGFR1 rearrangements in myeloproliferative disorders: Identification of the t(8;17)(p11;q25) as a new cytogenetic variant
74. The Ced-3/interleukin 1 beta converting enzyme-like homolog Mch6 and the lamin-cleaving enzyme Mch2alpha are substrates for the apoptotic mediator CPP32
75. Src homology 2-containing inositol 5-phosphatase 1 binds to the multifunctional docking site of c-Met and potentiates hepatocyte growth factor-induced branching tubulogenesis
76. TOR signalling and control of cell growth
77. Differential expression assay of chromosome arm 8p genes identifies Frizzied-related (FRP1/FRZB) and fibroblast growth factor receptor 1 (FGFR1) as candidate breast cancer gcnes
78. Structural determinants of phosphoinisitide 3-kinase by wortmannin, LY294002, quercetin, myricetin, and staurosporine
79. Fibroblast growth factor receptors have different signaling and mitogenie potentials
80. Broadly expressed SNT-like proteins link FGF receptor stimulation to activators of Ras
81. Constitutive activation of STAT proteins in primary lymphoid and myeloid leukemia cells and in Epstein-Barr virus (EBV)-related lymphoma cell lines
82. FGFR activation in skeletal disorders: Too much of a good thing
83. Structure and function of phosphoinositide 3-kinases
84. FGFR1 is fused with a novel zinc-finger gene, ZNF198, in the t(8;13) leukaemia/lymphoma syndrome
85. ZNF198-FGFR1 transforming activity depends on a novel proline-rich ZNF198 oligomerization domain
86. Novel recognition motif on fibroblast growth factor receptor mediates direct association and activation of SNT adapter proteins
87. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR